Exudative Age-Related Macular Degeneration
In Case You Missed…Advancing Outcomes in Retinal Disease
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Geographic Atrophy Secondary to AMD: Optimizing Patient Selection for Novel Therapeutics
This activity is supported by educational grants from Astellas and Topcon Healthcare, Inc.
SimulatED: Pioneering Treat and Extend Therapy – The Impact of Early Application
This activity is supported by an educational grant from MJH Associates, Inc.; Regeneron Healthcare Solutions, Inc.
Geographic Atrophy Secondary to Age-Related Macular Degeneration: Innovative Therapies for Sight Revival
This activity is supported by educational grants from Apellis Pharmaceuticals, Inc., and Topcon Healthcare, Inc.
nAMD and DME Management: Scaling Real-World Heights in Durability
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Curbside Consults: A Patient With Treatment-Resistant DME
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Asian patients with central serous chorioretinopathy at increased risk for exudative AMD
Adults with central serous chorioretinopathy are at higher risk for exudative age-related macular degeneration, particularly in Asian populations, according to a nationwide cohort study conducted in South Korea.
Home OCT with AI analysis may lead to ‘paradigm shift’ in AMD management
A novel artificial intelligence-based algorithm for automatic retinal fluid quantification in home OCT images performed comparably to human readers, according to a presentation from the virtual American Society of Retina Specialists meeting.
Management of diabetes-related eye disease moves toward flexible, personalized approaches
TREVISO, Italy — Management of diabetic retinopathy requires flexible, personalized approaches, which new advances are making possible.